Gradalis Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Private

  • Employees
  • 38

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Financing Rounds
  • 8

Gradalis General Information

Description

Developer of drugs, vaccines, tools and diagnostics intended to treat cancer. The company's products specialize in the development and commercialization of novel personalized therapeutics to treat cancer, enabling health organizations to provide advanced drugs.

Contact Information

Website
www.gradalisinc.com
Formerly Known As
Murex Pharmaceuticals
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • 2545 Golden Bear Drive
  • Suite 110
  • Carrollton, TX 75006
  • United States
+1 (214)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Oncology
Corporate Office
  • 2545 Golden Bear Drive
  • Suite 110
  • Carrollton, TX 75006
  • United States
+1 (214)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Gradalis Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Gradalis‘s full profile, request access.

Request a free trial

Gradalis Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of drugs, vaccines, tools and diagnostics intended to treat cancer. The company's products specialize in the d
Drug Discovery
Carrollton, TX
38 As of 2023

Middleton, WI
 

Oxford, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Gradalis Competitors (102)

One of Gradalis’s 102 competitors is Centrose, a Venture Capital-Backed company based in Middleton, WI.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Centrose Venture Capital-Backed Middleton, WI
Enara Bio Venture Capital-Backed Oxford, United Kingdom
Repertoire Immune Medicines Venture Capital-Backed Cambridge, MA
Kymera Therapeutics Formerly VC-backed Watertown, MA
EdiGene Venture Capital-Backed Beijing, China
You’re viewing 5 of 102 competitors. Get the full list »

Gradalis Patents

  • 109

    Total Documents Applications and Grants

  • Total Patents Families

  • 73

    Granted

  • 13

    Pending

  • Expiring in next 12 mo

Gradalis Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4440704-A2 Methods for treatment response to cancers Pending 30-Nov-2021
US-20250003010-A1 Methods for treatment response to cancers Pending 30-Nov-2021
EP-4305175-A1 Methods for treating cancers Pending 10-Mar-2021
US-20240189450-A1 Methods for treating cancers Pending 10-Mar-2021
US-20230338284-A1 Methods for the treatment of lung tumors Pending 09-Sep-2020 A61K9/0075
To view Gradalis’s complete patent history, request access »

Gradalis Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Gradalis Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Gradalis‘s full profile, request access.

Request a free trial

Gradalis FAQs

  • When was Gradalis founded?

    Gradalis was founded in 2003.

  • Where is Gradalis headquartered?

    Gradalis is headquartered in Carrollton, TX.

  • What is the size of Gradalis?

    Gradalis has 38 total employees.

  • What industry is Gradalis in?

    Gradalis’s primary industry is Drug Discovery.

  • Is Gradalis a private or public company?

    Gradalis is a Private company.

  • What is Gradalis’s current revenue?

    The current revenue for Gradalis is .

  • How much funding has Gradalis raised over time?

    Gradalis has raised $89.7M.

  • Who are Gradalis’s investors?

    WP Global Partners, Cancer Prevention and Research Institute of Texas, and U.S. Department of Health and Human Services have invested in Gradalis.

  • Who are Gradalis’s competitors?

    Centrose, Enara Bio, Repertoire Immune Medicines, Kymera Therapeutics, and EdiGene are some of the 102 competitors of Gradalis.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »